278 related articles for article (PubMed ID: 27762310)
1. Chromatin accessibility contributes to simultaneous mutations of cancer genes.
Shi Y; Su XB; He KY; Wu BH; Zhang BY; Han ZG
Sci Rep; 2016 Oct; 6():35270. PubMed ID: 27762310
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of somatic mutations and epigenetic alterations in insulated neighbourhood boundaries.
Pinoli P; Stamoulakatou E; Nguyen AP; Rodríguez Martínez M; Ceri S
PLoS One; 2020; 15(1):e0227180. PubMed ID: 31945090
[TBL] [Abstract][Full Text] [Related]
3. Chromatin loop anchors are associated with genome instability in cancer and recombination hotspots in the germline.
Kaiser VB; Semple CA
Genome Biol; 2018 Jul; 19(1):101. PubMed ID: 30060743
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the 3D cancer genome blueprint.
Achinger-Kawecka J; Clark SJ
Epigenomics; 2017 Jan; 9(1):47-55. PubMed ID: 27936932
[TBL] [Abstract][Full Text] [Related]
5. Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.
Guo YA; Chang MM; Huang W; Ooi WF; Xing M; Tan P; Skanderup AJ
Nat Commun; 2018 Apr; 9(1):1520. PubMed ID: 29670109
[TBL] [Abstract][Full Text] [Related]
6. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.
Lee CA; Abd-Rabbo D; Reimand J
Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236
[TBL] [Abstract][Full Text] [Related]
7. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in colorectal cancer are associated with the epigenetic modifications.
Lei H; Tao K
J Cell Mol Med; 2020 Oct; 24(20):11828-11836. PubMed ID: 32865336
[TBL] [Abstract][Full Text] [Related]
9. Identification of Cancer Drivers at CTCF Insulators in 1,962 Whole Genomes.
Liu EM; Martinez-Fundichely A; Diaz BJ; Aronson B; Cuykendall T; MacKay M; Dhingra P; Wong EWP; Chi P; Apostolou E; Sanjana NE; Khurana E
Cell Syst; 2019 May; 8(5):446-455.e8. PubMed ID: 31078526
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA HOTTIP cooperates with CCCTC-binding factor to coordinate HOXA gene expression.
Wang F; Tang Z; Shao H; Guo J; Tan T; Dong Y; Lin L
Biochem Biophys Res Commun; 2018 Jun; 500(4):852-859. PubMed ID: 29698677
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial patterns of somatic gene mutations in cancer.
Yeang CH; McCormick F; Levine A
FASEB J; 2008 Aug; 22(8):2605-22. PubMed ID: 18434431
[TBL] [Abstract][Full Text] [Related]
12. Functional Mutations Form at CTCF-Cohesin Binding Sites in Melanoma Due to Uneven Nucleotide Excision Repair across the Motif.
Poulos RC; Thoms JAI; Guan YF; Unnikrishnan A; Pimanda JE; Wong JWH
Cell Rep; 2016 Dec; 17(11):2865-2872. PubMed ID: 27974201
[TBL] [Abstract][Full Text] [Related]
13. Heterarchy of transcription factors driving basal and luminal cell phenotypes in human urothelium.
Fishwick C; Higgins J; Percival-Alwyn L; Hustler A; Pearson J; Bastkowski S; Moxon S; Swarbreck D; Greenman CD; Southgate J
Cell Death Differ; 2017 May; 24(5):809-818. PubMed ID: 28282036
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationships explain CTCF zinc finger mutation phenotypes in cancer.
Bailey CG; Gupta S; Metierre C; Amarasekera PMS; O'Young P; Kyaw W; Laletin T; Francis H; Semaan C; Sharifi Tabar M; Singh KP; Mullighan CG; Wolkenhauer O; Schmitz U; Rasko JEJ
Cell Mol Life Sci; 2021 Dec; 78(23):7519-7536. PubMed ID: 34657170
[TBL] [Abstract][Full Text] [Related]
15. Greater Than the Sum of Parts: Complexity of the Dynamic Epigenome.
Soshnev AA; Josefowicz SZ; Allis CD
Mol Cell; 2016 Jun; 62(5):681-94. PubMed ID: 27259201
[TBL] [Abstract][Full Text] [Related]
16. CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer.
Bailey CG; Metierre C; Feng Y; Baidya K; Filippova GN; Loukinov DI; Lobanenkov VV; Semaan C; Rasko JE
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513694
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 offers a new tool for studying the role of chromatin architecture in disease pathogenesis.
Guo X; Dean A
Genome Biol; 2018 Nov; 19(1):185. PubMed ID: 30400943
[TBL] [Abstract][Full Text] [Related]
18. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
[TBL] [Abstract][Full Text] [Related]
19. Crossed wires: 3D genome misfolding in human disease.
Norton HK; Phillips-Cremins JE
J Cell Biol; 2017 Nov; 216(11):3441-3452. PubMed ID: 28855250
[TBL] [Abstract][Full Text] [Related]
20. Cell-of-origin chromatin organization shapes the mutational landscape of cancer.
Polak P; Karlić R; Koren A; Thurman R; Sandstrom R; Lawrence M; Reynolds A; Rynes E; Vlahoviček K; Stamatoyannopoulos JA; Sunyaev SR
Nature; 2015 Feb; 518(7539):360-364. PubMed ID: 25693567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
